{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16(11)"],"submitter":["Cherney DZI"],"funding":["Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance"],"journal":["Clinical journal of the American Society of Nephrology : CJASN"],"pagination":["1715-1719"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8729416"],"repository":["biostudies-literature"],"pubmed_title":["Kidney Effects of Empagliflozin in People with Type 1 Diabetes."],"pmcid":["PMC8729416"],"pubmed_authors":["Neubacher D","Cherney DZI","Marquard J","Rosenstock J","Bjornstad P","Perkins BA","Soleymanlou N"],"additional_accession":[]},"is_claimable":false,"name":"Kidney Effects of Empagliflozin in People with Type 1 Diabetes.","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Nov","modification":"2025-04-04T22:33:49.981Z","creation":"2025-02-19T03:24:03.913Z"},"accession":"S-EPMC8729416","cross_references":{"pubmed":["34535454"],"doi":["10.2215/cjn.07700621","10.2215/CJN.07700621"]}}